Loading…
Ezetimibe acts by decreasing cholesterol absorption in the small intestine and lowers plasma cholesterol levels
Clostridium XVIII and Lachnospiracea incertae sedis were negatively correlated with total cholesterol (TC) and LDL-C after ezetimibe intervention
In contrast, TG, total cholesterol (TC), and low-density lipoprotein cholesterol (LDL-C) were significantly decreased by ezetimibe
Ezetimibe is a hypolipidemic drug that selectively inhibits cholesterol absorption by attaching to the brush border of the villi epithelium of the small intestine